AbbVie Inc news

   Watch this stock
Showing stories 1 - 10 of about 158   

Articles published

ABBV 94.49 -0.01 (-0.01%)
price chart
The case for Johnson & Johnson
Several products are largely responsible for driving that growth, especially Imbruvica (for which J&J receives a smaller percentage of sales than AbbVie, though), blood cancer drug Darzalex, and Stelara, which treats psoriasis and psoriatic arthritis ...
Dividend Aristocrats In Focus Part 45: AbbVie
The Dividend Aristocrats are a group of 51 companies in the S&P 500 Index, with 25+ consecutive years of dividend increases. You can see all 51 Dividend Aristocrats here.
AbbVie: Another Spectacular Quarter From This Dividend Aristocrat
The company's performance in the quarter was fantastic. Revenues increased by ~9% while adjusted diluted earnings-per-share expanded by ~17%.
AbbVie Inc. (ABBV) Expected to Announce Earnings of $1.43 Per Share
AbbVie logo Equities research analysts forecast that AbbVie Inc. (NYSE:ABBV) will announce earnings per share of $1.43 for the current fiscal quarter, according to Zacks Investment Research.
Valley National Advisers Inc. Has $1.07 Million Position in AbbVie Inc. (ABBV)  TrueBlueTribune
AbbVie Inc. (ABBV) Shares Sold by Brookstone Capital Management  The Lincolnian Online
Lookout for Price Target? AbbVie Inc. (ABBV), Spirit Airlines, Inc. (SAVE)
Investors who are keeping close eye on the stock of AbbVie Inc. (NYSE:ABBV) established that the company was able to keep return on investment at 11.73 in the trailing twelve month while Reuters data showed that industry's average stands at 15.11 and ...
AbbVie says Humira sales will balloon to $21 billion in 2020, shares rise
AbbVie also reported third-quarter earnings above Wall Street estimates, as it sold more of Humira - the world's best selling prescription medicine - and Imbruvica, its other main drug.
AbbVie Inc (ABBV) Earnings: 12 Things to Know  Investorplace.com
Checking the Overall Picture for AbbVie Inc. (ABBV)  StockNewsJournal
AbbVie Inc. (ABBV) EVP Michael Severino Sells 25633 Shares
AbbVie logo AbbVie Inc. (NYSE:ABBV) EVP Michael Severino sold 25,633 shares of the firm's stock in a transaction on Friday, November 10th.
Diehard Bargain Hunter: AbbVie Inc. (ABBV), The Wendy's Company (WEN)  AllStockNews
Physicians Financial Services, Inc. Buys DowDuPont Inc, Red Hat Inc, AbbVie ...
Physicians Financial Services, Inc. initiated holdings in AbbVie Inc. The purchase prices were between $69.85 and $89.22, with an estimated average price of $76.06.
AbbVie Promises Too Much, Risks Delivering Too Little: Gadfly
AbbVie Inc. has gotten some wins lately. But it may be guilty of over-celebrating. The company provided boosted long-term sales forecasts last week, commemorating strong third-quarter sales of its lead drug Humira and a deal with Amgen Inc. that will ...
What's Acceptable Profitability For Spirit Realty Capital, Inc. (SRC) and ...
Shares of Spirit Realty Capital, Inc. (NYSE:SRC) are on a recovery track as they have regained 28.92% since bottoming out on May.